Pharmaceutical compositions for the treatment of visual system disorders
AssigneeAllergan, Inc.
InventorsAlan C. Foster, Yong-Xin Li, Ursula V. Staubli
Life of this patent
Estimating the term…
Abstract
The present invention relates to pharmaceutical compositions comprising D-serine transporter inhibitors which are proline analogues and therapeutic methods using such pharmaceutical compositions in methods for the treatment of visual system disorders and the enhancement of the visual function.
Claims7
A method for the treatment of visual system disorders caused by a deficit in N-methyl-D-aspartate receptor function, the method comprising administering to a subject in need thereof an ophthalmically acceptable pharmaceutical composition containing a therapeutically effective amount of one or more D-serine transporter inhibitor compounds which are proline analogues.
A method for the enhancement of the visual function, the method comprising administering to a subject in need thereof, an ophthalmically acceptable pharmaceutical composition containing a therapeutically effective amount of one or more D-serine transporter inhibitor compounds which are proline analogues.
Dependencies are inferred from the claim text.